Ann Pole

551 total citations
14 papers, 425 citations indexed

About

Ann Pole is a scholar working on Immunology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ann Pole has authored 14 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 3 papers in Molecular Biology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ann Pole's work include Immunodeficiency and Autoimmune Disorders (3 papers), Immune Cell Function and Interaction (3 papers) and Malaria Research and Control (3 papers). Ann Pole is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (3 papers), Immune Cell Function and Interaction (3 papers) and Malaria Research and Control (3 papers). Ann Pole collaborates with scholars based in United States, Australia and Papua New Guinea. Ann Pole's co-authors include Maurine R. Hobbs, J. Brice Weinberg, Marc C. Levesque, Donald L. Granger, Nicholas M. Anstey, Hilary Coon, Esther D. Mwaikambo, Ariana N. Tkachuk, Bernard L. Nahlen and Jacquelin M. Roberts and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and The Journal of Infectious Diseases.

In The Last Decade

Ann Pole

13 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann Pole United States 9 122 115 74 65 48 14 425
Libin Chen China 16 64 0.5× 147 1.3× 300 4.1× 134 2.1× 22 0.5× 64 797
Tohti Amet United States 15 45 0.4× 213 1.9× 106 1.4× 110 1.7× 21 0.4× 26 461
Michael Mirsky United States 10 31 0.3× 254 2.2× 90 1.2× 28 0.4× 9 0.2× 19 517
Achut G. Malur United States 18 24 0.2× 253 2.2× 233 3.1× 218 3.4× 56 1.2× 32 860
Hidemitsu Higashi Japan 7 56 0.5× 365 3.2× 121 1.6× 119 1.8× 66 1.4× 8 618
Callum Kay Australia 8 43 0.4× 169 1.5× 516 7.0× 44 0.7× 24 0.5× 11 725
Laura Visconti Italy 9 41 0.3× 99 0.9× 176 2.4× 110 1.7× 22 0.5× 10 462
Alexandre L. N. Silva Brazil 9 296 2.4× 215 1.9× 339 4.6× 150 2.3× 18 0.4× 9 670
Matthew Laver Australia 4 24 0.2× 109 0.9× 122 1.6× 53 0.8× 13 0.3× 6 379
Thomas Jacob United States 15 100 0.8× 91 0.8× 194 2.6× 243 3.7× 27 0.6× 29 776

Countries citing papers authored by Ann Pole

Since Specialization
Citations

This map shows the geographic impact of Ann Pole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Pole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Pole more than expected).

Fields of papers citing papers by Ann Pole

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Pole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Pole. The network helps show where Ann Pole may publish in the future.

Co-authorship network of co-authors of Ann Pole

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Pole. A scholar is included among the top collaborators of Ann Pole based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Pole. Ann Pole is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Fornadi, Katalin, et al.. (2026). Early posttransplant rituximab use in kidney transplant recipients with preexisting donor-specific antibodies. Renal Failure. 48(1). 2620179–2620179.
2.
Profaizer, Tracie, et al.. (2020). Clinical utility of next generation sequencing based HLA typing for disease association and pharmacogenetic testing. Human Immunology. 81(7). 354–360. 13 indexed citations
3.
Profaizer, Tracie, et al.. (2018). P082 HLA disease association testing by NGS: Is it superior to other methods?. Human Immunology. 79. 121–121. 1 indexed citations
4.
Profaizer, Tracie, Eszter Lázár‐Molnár, Ann Pole, Julio C. Delgado, & Attila Kumánovics. (2017). HLA genotyping using the Illumina HLA TruSight next‐generation sequencing kits: A comparison. International Journal of Immunogenetics. 44(4). 164–168. 9 indexed citations
5.
Lázár‐Molnár, Eszter, et al.. (2015). The effect of pronase on lymphocyte surface markers and implications for flow cytometric crossmatch. Human Immunology. 76. 131–131. 2 indexed citations
6.
Lázár‐Molnár, Eszter, et al.. (2015). Residual serum rituximab induces false positive flow cytometric B cell crossmatch more than 6months post-infusion. Human Immunology. 76. 128–128. 1 indexed citations
7.
Lu, Zhenyu, Ryan M. Van Wagoner, Ann Pole, et al.. (2013). Myristicyclins A and B: Antimalarial Procyanidins fromHorsfieldia spicatafrom Papua New Guinea. Organic Letters. 16(2). 346–349. 16 indexed citations
8.
Bugni, Tim S., et al.. (2009). Biologically active components of a Papua New Guinea analgesic and anti-inflammatory lichen preparation. Fitoterapia. 80(5). 270–273. 47 indexed citations
9.
Barrows, Louis R., Teatulohi Matainaho, Scott E. Miller, et al.. (2009). Making the most of Papua New Guinea’s biodiversity: Establishment of an integrated set of programs that link botanical survey with pharmacological assessment in “the land of the unexpected”. Pharmaceutical Biology. 47(8). 795–808. 6 indexed citations
10.
Levesque, Marc C., Maurine R. Hobbs, Charles W. O’Loughlin, et al.. (2009). Malaria severity and human nitric oxide synthase type 2 (NOS2) promoter haplotypes. Human Genetics. 127(2). 163–182. 21 indexed citations
11.
Hobbs, Maurine R., Venkatachalam Udhayakumar, Marc C. Levesque, et al.. (2002). A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. The Lancet. 360(9344). 1468–1475. 150 indexed citations
12.
Hobbs, Maurine R., Ann Pole, Irving B. Rosen, et al.. (1999). Hyperparathyroidism–Jaw Tumor Syndrome: The HRPT2 Locus Is within a 0.7-cM Region on Chromosome 1q. The American Journal of Human Genetics. 64(2). 518–525. 44 indexed citations
13.
Levesque, Marc C., Maurine R. Hobbs, Nicholas M. Anstey, et al.. (1999). Nitric Oxide Synthase Type 2 Promoter Polymorphisms, Nitric Oxide Production, and Disease Severity in Tanzanian Children with Malaria. The Journal of Infectious Diseases. 180(6). 1994–2002. 71 indexed citations
14.
Cole, B C, Kevin L. Knudtson, Arnold Oliphant, et al.. (1996). The sequence of the Mycoplasma arthritidis superantigen, MAM: identification of functional domains and comparison with microbial superantigens and plant lectin mitogens.. The Journal of Experimental Medicine. 183(3). 1105–1110. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026